The STEP trials demonstrated weight reductions of approximately 14.9% on average, and the SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major adverse cardiovascular events in overweight and obese non-diabetic patients, transforming obesity into a cardiovascular indication and massively expanding the prescribing universe and reimbursement coverage
AgelessRx is the only provider in our evaluation that asks: Prior to discovering AgelessRx, how important was the idea of longevity or slowing down aging to you? with a 5-point scale from No importance / dont care to Significant importance. This question has no clinical function its a brand positioning tool that signals AgelessRxs target patient: someone who thinks about health-span and aging, not just the number on a scale
a process associated with aggressive proliferation and poor patient prognosis (69,70)
When taking semaglutide, the ultimate goal is forging a healthier life, and semaglutide helps give a boost when these good habits are already in place
Clinical trial data suggests slightly higher adverse event rates with retatrutide compared to tirzepatide
A box of 5 bottles is designed for approximately 6 weeks of use
